NTRK1 and glioblastoma: Abnormal activation of receptor tyrosine kinase signaling pathways is frequently observed in glioblastoma, and STAT3 activation is often accompanied by epidermal growth factor receptor (EGFR) overexpression in high-grade gliomas3.